The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.

NCT05816694 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Histological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma

Interventions

DRUG: NAB-Paclitaxel plus Cisplatin
DRUG: Cisplatin plus Epirubicin plus Cyclophosphamide

Sponsor

Peng Liu